strains has recently been restated by several authors (Igarashi, I984; Monath, 1986) and this variation may be the origin of virulence in human hosts and of infective capacity of mosquito vectors. The heterogeneity of epidemic dengue virus strains has been shown both serologically and at the molecular level. However, it is not clear which genomic changes may be related with the virulence of a particular strain.
Dengue virus has an approximately 11 kb single-stranded RNA genome (Rice et al., 1986) and three structural proteins: the capsid (C), the membrane (M) protein and the envelope (E) protein. The E protein (,~ 500 aa) acts as the viral haemagglutinin, induces a protective immune response and mediates receptor-specific virus attachment to the cell surface; it is also the major antigenic component on the surface of the dengue virion (Ng & Lau, 1988) . The E protein is thought to play a role in the pathogenicity of several viruses, either by defining cellular tropism or by affecting virus penetration (Rusell el: al., 1989) .
Specific sequence changes in the E protein have yet to be directly associated with alterations in the biological activity of flaviviruses. However, sequence differences in the E-geneattenuated strains of Yellow fever virus (YFV), Japanese encephalitis virus (JEV), Tick-borne encephalitis virus (TBE) and Murray Valley encephalitis virus (MVE) have been associated with reduced pathogenicity (Hahn eta] ., 1987; Nitayaphan et al., 1990; Holzmann et a] ., Lobigs eta] ., 1990). Earlier studies suggested that new dengue isolates contain mixtures of virion populations with different virulence properties. A mixture of large-and small-plaque variants were also detected in a DEN-2 strain isolated from a human case (Eckels et al., 1976) . Furthermore, the small-plaque variant appeared to correlate with mouse virulence, temperature sensitivity and attenuation in non-human primates (Harrison et a] ., 1977).
During plaque purification of a Mexican strain isolate of dengue virus (200787/1983 ) serotype 2 (D-2M), we detected D-2M clones with plaque sizes remarkably different from one another. To investigate whether significant differences were present between the E protein clones with different lytic plaque size and the possibility that they could influence the expression of virulence, we isolated, cloned and purified ii stable clones with different plaque sizes on LLC-MK2 cell monolayers and evaluated them in a murine encephalitis model (BALB/c suckling mice). Several large, medium and small plaques were selected and subjected to repeated plaque purifications, until homogeneous plaque size populations were obtained. Three clones were obtained (D2ML2, D2ML3 and D2ML4), producing plaques of 3-4 mm diameter; 4 clones (D2MMI, D2MM2, D2MM3 and D2MM4) producing plaques of 1"5-2 mm diameter, and 4 clones (D2MS1, D2MS2, D2MS3 and D2MS4) producing plaques of < I mm diameter (Table  I) . The viral stocks were separated and used to purify viral RNA and to inoculate it intracerebrally (i.c.) into BALB/c suckling mice. We applied the RNaseA mismatch detection method to analyse the genetic variability of RNA before sequence analysis of clone RNA to obtain a general pattern of the genomic heterogeneity. Viral RNA prepared from each D-2M clone was used for the assay and a radioactive antisense RNA probe corresponding to the E gene of the D-2PR strain was synthesized with T7 RNA polymerase using PvuII-pGEM4/E. RNA:RNA hybrids were digested with 60 lag of RNaseA (15 min at 3 7 °C) and the RNA fragments resistant to digestion were analysed by denaturing 6"8 % and 4 % gel electrophoresis.
A complex band pattern was observed with the full-length RNA probe, as expected. The digestion pattern was similar in several hybrids, with some differences. For instance D2MS2, D2MS4 and D2MM4 clones generated band patterns 100% identical to D2MS1. However, the band patterns of D2MS3, D2MM1 and D2MM3 were 83"7, 90"0 and 94"7% homologous, respectively. Finally, the D2MM2, D2ML2, D2ML3 and D2ML4 clones matched the bands of D2MS1 at a level of 78"2% or less (Table I) .
Mismatch cleavage results are indicative of genetic heterogeneity in the same viral isolate. However, this assay did not reveal the absolute genetic differences between viral clones. To determine differences at the genome level, each clone was sequenced. The E gene, which codes for the viral envelope protein, was amplified and cloned in a sequencing vector or used in direct sequencing of the PCR product.
The nucleotide sequence of the E region of each clone was determined and they were compared with one another and with the sequences of the D-2M strain. Most mutations were silent (Table 2) . When the amino acid sequences from clones with small plaque size (D2MS1, D2MS2 and D2MS4) were compared, they displayed the same sequence, which differed from the sequence of parental D-2M strain at only one position, namely residue 390 of the E protein where the Asp residue of D-2M was replaced by Asn in clones with small plaque size (Fig. 1) . The sequence of the D2MS3 clone contained two substitutions. One of them resulted in the same mutation as in the small plaque clone (Asp --+ Asn at residue 390) and the second in the substitution of Lys--+ Asn at position 388 (Table 2) .
Comparison between the amino acid sequence of the Ecoding region of D2ML2, D2ML3, D2ML4 and the D-2M strain sequence revealed no differences except at one location. The mutation consisted of the change of G in D-2M to C at nucleotide position 1168 in clones with large plaque size, resulting in the substitution of Asp in D-2M for His in D2ML clones at residue 390 (Fig. 1 ). All sequencing data were confirmed by direct-sequencing of DNA segments obtained by PCR from the nucleotide regions 1118 to 1320 where most mutations were located. The 11 clones or D-2M strains were subsequently tested to evaluate the effect of the mutation on neurovirulence in suckling mice, inoculating a dose of 6 x 106 p.f.u. (100 LDs0), i.c., of each clone per animal and observing them for 31 days for signs of encephalitis or death. As shown in Table 1 , three virulence patterns were identified: (1) highly virulent clones (D2ML2, D2ML3 and D2ML4), which produced 70-90% mortality; (2) intermediate virulence clones (D2MS3, D2MM1, D2MM2, D2MM3 and D2MM4), which showed variable mortality rates ( < 20 %), but characteristically were not lethal for animals, although they did cause symptoms of tremor, seizure and paralysis; and (3) low virulence clones (D2MS1, D2MS2 and D2MS4), which induced only mild symptoms (inactivity, slow movement, shaking, tremor and inability to stand). There was a significant difference between clones of different plaque size when the mice were inoculated i.c. This experiment was performed twice for a more accurate estimate of mouse neurovirulence.
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These experiments revealed a direct correlation between iiiiiiiiiiiiiiii iii iii ii ii iiiii iiiiiiiiiiiiiiiiiiiiiiiiiiii the percentage of genomic variability and the degree of virulence. Clones D2MS1, D2MS2, D2MS4 and D2MM4, which presented 100% homogeneity in electrophoretic patterns obtained by digestion of heterohybrids, showed attenuated virulence in mice (Table 1) . However, the clones showing 80 % homogeneity produced a severe infection (70 % or more mortality). The difference in electrophoretic patterns correlated with the number of substitutions of nucleotides in the E gene of each clone. Previous mutations were silent with the exception of the change at position 1168 (amino acid 390) in clones with attenuated or with severe virulence (Table 2) .
Multiple alignments with other isolates of dengue virus 2 were performed (Fig. I) . The clones showing attenuated virulence presented a substitution of Asp for Asn at residue 390 when compared with the parenteral strain (D-2M), and the Ash was also found in the vaccine strains. The clones showing high virulence have a substitution of Asp for His, and this His was also present at the same position (390) in dengue virus 2 isolates from Asia, where severe cases of dengue are more common. Interestingly, this substitution was also found in other flaviviruses that cause encephalitis such as JEV, MVE, Kunjin virus (KUN), and St Louis encephalitis virus (SLE). The mutation of Asp for His shown by clones D2ML2, D2ML3 and D2ML4 causes severe neurovirulence.
Several mutation sites that affect virulence in different flaviviruses have been described. These mutations occur in the E gene. Mutations at positions 52 (Hasegawa et al., 1992) , 271 and 336 (Cecilia et aI., 1991) have been observed in JEV; at position 390 in MVE virus (Lobig et aI., 1990) , at 104 and 107 in the tick-borne encephalitis virus/dengue virus 4 chimera (Pletnev et aI., 1993) , at 171 and 384 from TBE virus (Mandl et al., 1988) and they are responsible for specific properties of each strain. The position of mutations which influence flavivirus virulence occur in three different regions of the envelope protein: (1) the distal face of domain III (residues 303-395) has an IgC-like fold. Mutations in this region modify the capacity for virus binding to the cell, affecting viral internalization or cellular tropism; (2) the base of domain II (residues 52-136 and 190-284); (3) the contact between the domain I/domain III interface. This region is the site of dimerization or trimerization with monomers of the E protein upon contact of the virus with the cellular membrane (Rey et aL, 1995) .
The mutation observed in residue 390 of D-2 Mexican clones was localized in domain III. This is the first example of an immunoglobulin module on a viral surface protein (Rey et al., 1995) . Since these structures are directly related to cell adhesion, we believe that this domain plays a very important role in receptor-cell binding, in fact, any mutations in domain Ill could be related to the change in virulence in the presently examined clones. These results support the notion that the basic amino acid substitutions in the envelope protein of dengue virus, including aa 390, may be functionally important and are probably involved in receptor binding, which has been postulated from studies with several other flaviviruses. 
Alignment between parental virus and clones Alignment between clones and other geographic isolates of dengue virus 
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::::::::::::::::::::::::::: antiviral therapies and many other in vivo conditions that produce different patterns of disease. All the quasispecies in a single person appear to have the same origin; the status quo is likely to be the result of an accumulation of mutants from the original viral inoculum. In our case, the density of the population of dengue virulent clones ('quasispecies-like') could be relevant to the progress of the disease.
Definite answers to the genetics and structural basis of virulence differences will be obtained by specific engineering of infectious clones to demonstrate that these substitutions are responsible for virulence. Virulence could be reverted by sitedirected mutagenesis of RNA from non-virulent to virulent clones. Our results provide valuable information for such experiments in the future.
